{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:19:28Z","timestamp":1770891568072,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00408-018-0111-0","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T04:58:25Z","timestamp":1521608305000},"page":"315-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-5908","authenticated-orcid":false,"given":"Vikas","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Aris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert James","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"issue":"5","key":"111_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D\u2019Alonzo","year":"1991","unstructured":"D\u2019Alonzo GE, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115(5):343\u2013349","journal-title":"Ann Intern Med"},{"issue":"2","key":"111_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ Rubin","year":"1997","unstructured":"Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336(2):111\u2013117","journal-title":"N Engl J Med"},{"issue":"2","key":"111_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","volume":"107","author":"S Rich","year":"1987","unstructured":"Rich S, Dantzker DR, Ayres SM et al (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107(2):216\u2013223","journal-title":"Ann Intern Med"},{"issue":"2 Pt 1","key":"111_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","volume":"161","author":"S Miyamoto","year":"2000","unstructured":"Miyamoto S, Nagaya N, Satoh T et al (2000) Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161(2 Pt 1):487\u2013492","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"111_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/hc2901.093198","volume":"104","author":"XG Sun","year":"2001","unstructured":"Sun XG, Hansen JE, Oudiz RJ et al (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429\u2013435","journal-title":"Circulation"},{"issue":"20","key":"111_CR6","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/01.CIR.101.20.2388","volume":"101","author":"R Wensel","year":"2000","unstructured":"Wensel R, Opitz CF, Ewert R et al (2000) Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation 101(20):2388\u20132392","journal-title":"Circulation"},{"issue":"2","key":"111_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/hrt.79.2.175","volume":"79","author":"TW Higenbottam","year":"1998","unstructured":"Higenbottam TW, Butt AY, Dinh-Xaun AT et al (1998) Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart 79(2):175\u2013179","journal-title":"Heart"},{"issue":"9288","key":"111_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","volume":"358","author":"RN Channick","year":"2001","unstructured":"Channick RN, Simonneau G, Sitbon O et al (2001) Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358(9288):1119\u20131123","journal-title":"Lancet"},{"issue":"9","key":"111_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","volume":"39","author":"N Galie","year":"2002","unstructured":"Galie N, Humbert M, Vachiery JL et al (2002) Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 39(9):1496\u20131502","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"111_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa020204","volume":"347","author":"H Olschewski","year":"2002","unstructured":"Olschewski H, Simonneau G, Galie N et al (2002) Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347(5):322\u2013329","journal-title":"N Engl J Med"},{"issue":"4","key":"111_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0735-1097(02)02032-6","volume":"40","author":"S Kruger","year":"2002","unstructured":"Kruger S, Graf J, Kunz D et al (2002) Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40(4):718\u2013722","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"111_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","volume":"96","author":"T Tsutamoto","year":"1997","unstructured":"Tsutamoto T, Wada A, Maeda K et al (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96(2):509\u2013516","journal-title":"Circulation"},{"issue":"11","key":"111_CR13","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/01.CIR.93.11.1963","volume":"93","author":"T Omland","year":"1996","unstructured":"Omland T, Aakvaag A, Bonarjee VV et al (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93(11):1963\u20131969","journal-title":"Circulation"},{"issue":"7","key":"111_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","volume":"38","author":"J Koglin","year":"2001","unstructured":"Koglin J, Pehlivanli S, Schwaiblmair M et al (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38(7):1934\u20131941","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"111_CR15","first-page":"929","volume":"2","author":"MR Burger","year":"2001","unstructured":"Burger MR, Burger AJ (2001) BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Curr Opin Investig Drugs 2(7):929\u2013935","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"111_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/01.CIR.0000020009.30736.3F","volume":"106","author":"AP Bolger","year":"2002","unstructured":"Bolger AP, Sharma R, Li W et al (2002) Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92\u201399","journal-title":"Circulation"},{"issue":"4","key":"111_CR17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.33549\/physiolres.931773","volume":"59","author":"J Krupicka","year":"2010","unstructured":"Krupicka J, Janota T, Kasalova Z et al (2010) Effect of short-term maximal exercise on BNP plasma levels in healthy individuals. Physiol Res 59(4):625\u2013628","journal-title":"Physiol Res"},{"issue":"5","key":"111_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1527-5299.2004.03881.x","volume":"10","author":"MH Park","year":"2004","unstructured":"Park MH, Scott RL, Uber PA et al (2004) Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest Heart Fail 10(5):221\u2013225","journal-title":"Congest Heart Fail"},{"issue":"4","key":"111_CR19","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1378\/chest.128.4.2368","volume":"128","author":"HH Leuchte","year":"2005","unstructured":"Leuchte HH, Holzapfel M, Baumgartner RA et al (2005) Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 128(4):2368\u20132374","journal-title":"Chest"},{"issue":"17","key":"111_CR20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB et al (2009) ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53(17):1573\u20131619","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"111_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","volume":"102","author":"N Nagaya","year":"2000","unstructured":"Nagaya N, Nishikimi T, Uematsu M et al (2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102(8):865\u2013870","journal-title":"Circulation"},{"issue":"5","key":"111_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","volume":"129","author":"A Fijalkowska","year":"2006","unstructured":"Fijalkowska A, Kurzyna M, Torbicki A et al (2006) Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129(5):1313\u20131321","journal-title":"Chest"},{"issue":"1 Suppl","key":"111_CR23","first-page":"14S-34S","volume":"126","author":"M McGoon","year":"2004","unstructured":"McGoon M, Gutterman D, Steen V et al (2004) Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):14S-34S","journal-title":"Chest"},{"issue":"24","key":"111_CR24","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","volume":"25","author":"N Galie","year":"2004","unstructured":"Galie N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243\u20132278","journal-title":"Eur Heart J"},{"issue":"12 Suppl S","key":"111_CR25","first-page":"40S-47S","volume":"43","author":"RJ Barst","year":"2004","unstructured":"Barst RJ, McGoon M, Torbicki A et al (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):40S-47S","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"111_CR26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMra040291","volume":"351","author":"M Humbert","year":"2004","unstructured":"Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351(14):1425\u20131436","journal-title":"N Engl J Med"},{"issue":"1","key":"111_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111\u2013117","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-018-0111-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0111-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0111-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T15:55:59Z","timestamp":1660665359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-018-0111-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1007\/s00408-018-0111-0","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"23 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors report no real or potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}